SW · Healthcare

Addex Therapeutics Ltd (ADXN)

Biotechnology

Addex Therapeutics Ltd (ADXN) is listed on SW in the Healthcare sector. Industry: Biotechnology. As of 2026-03-22, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for ADXN

P/E ratio

18.00

Addex Therapeutics Ltd (ADXN) — FAQ

What is ADXN's P/E ratio?

The price-to-earnings (P/E) ratio for Addex Therapeutics Ltd (ADXN) is 18.00 (data as of 2026-03-22).

Does Addex Therapeutics Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Addex Therapeutics Ltd (ADXN). Check the MyAverix Finance app for the latest dividend data.

What sector is Addex Therapeutics Ltd in?

Addex Therapeutics Ltd (ADXN) is classified in the Healthcare sector (Biotechnology industry).

What exchange is ADXN listed on?

ADXN is listed on SW.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)